Clinical Trial Update: Anakinra for COVID-19 Respiratory Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial of anakinra for COVID-19 respiratory symptoms has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: University Hospital, Tours | Conditions: COVID-19 Infection, ANAKINRA Treatment | Phase 3 | Status: TERMINATED